Total Payments
$8,800
2024 Payments
$786.11
Companies
47
Transactions
344
Medicare Patients
10,192
Medicare Billing
$859,439
Payment Breakdown by Category
Food & Beverage$7,463 (84.8%)
Travel$1,015 (11.5%)
Consulting$300.00 (3.4%)
Education$21.48 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,463 | 336 | 84.8% |
| Travel and Lodging | $1,015 | 5 | 11.5% |
| Consulting Fee | $300.00 | 1 | 3.4% |
| Education | $21.48 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,312 | 63 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $694.31 | 41 | $0 (2024) |
| PFIZER INC. | $527.38 | 40 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $510.69 | 29 | $0 (2024) |
| Boston Scientific Corporation | $384.27 | 19 | $0 (2023) |
| ABIOMED | $344.90 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $343.15 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $252.30 | 10 | $0 (2021) |
| Amgen Inc. | $244.97 | 15 | $0 (2021) |
| Medtronic, Inc. | $208.77 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $786.11 | 33 | Lexicon Pharmaceuticals, Inc. ($162.73) |
| 2023 | $583.29 | 26 | Abbott Laboratories ($130.47) |
| 2022 | $1,093 | 42 | ABIOMED ($183.97) |
| 2021 | $446.03 | 19 | Janssen Pharmaceuticals, Inc ($137.45) |
| 2020 | $313.81 | 19 | Abbott Laboratories ($46.97) |
| 2019 | $1,525 | 70 | Abbott Laboratories ($416.80) |
| 2018 | $2,272 | 68 | Abbott Laboratories ($1,473) |
| 2017 | $1,780 | 67 | Abbott Laboratories ($1,022) |
All Payment Transactions
344 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ENDOTRONIX, INC. | CORDELLA PULOMONARY ARTERY PRESSURE SENSOR (Device) | Food and Beverage | Cash or cash equivalent | $22.53 | General |
| Category: HEART FAILURE | ||||||
| 11/12/2024 | Teleflex LLC | MANTA (Device) | Food and Beverage | In-kind items and services | $36.95 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.49 | General |
| 10/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: CARDIOLOGY | ||||||
| 09/17/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.82 | General |
| Category: Cardiovascular | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Heart Failure | ||||||
| 07/03/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.36 | General |
| 06/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Cardiovascular | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/08/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.37 | General |
| 05/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.14 | General |
| Category: Cardiovascular | ||||||
| 04/30/2024 | Medtronic, Inc. | PENDITURE (Device) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Ablation | ||||||
| 04/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,364 | 3,743 | $818,335 | $211,188 |
| 2022 | 24 | 2,484 | 3,878 | $759,605 | $201,969 |
| 2021 | 28 | 2,779 | 4,371 | $867,035 | $247,149 |
| 2020 | 26 | 2,565 | 3,798 | $666,960 | $199,133 |
Total Patients
10,192
Total Services
15,790
Medicare Billing
$859,439
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 578 | 1,005 | $252,200 | $93,172 | 36.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 86 | 168 | $31,810 | $16,395 | 51.5% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 20 | 20 | $44,000 | $14,233 | 32.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 650 | 1,091 | $141,830 | $11,055 | 7.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 168 | $25,000 | $10,847 | 43.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 60 | $20,810 | $8,532 | 41.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 63 | 70 | $17,280 | $7,419 | 42.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 35 | 38 | $57,000 | $6,571 | 11.5% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 21 | 21 | $37,800 | $6,138 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 71 | $10,770 | $4,212 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $9,450 | $4,049 | 42.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 28 | $8,450 | $3,990 | 47.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 26 | 46 | $9,200 | $2,910 | 31.6% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 38 | 95 | $14,250 | $2,886 | 20.3% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 67 | 163 | $24,450 | $2,863 | 11.7% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 25 | 25 | $27,650 | $2,582 | 9.3% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 21 | 36 | $9,000 | $2,406 | 26.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 35 | 92 | $13,800 | $2,018 | 14.6% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 34 | 72 | $21,600 | $2,003 | 9.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 12 | 12 | $9,600 | $1,977 | 20.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 230 | 256 | $15,360 | $1,683 | 11.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 29 | 48 | $4,800 | $990.29 | 20.6% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 13 | 15 | $2,875 | $916.80 | 31.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 65 | 70 | $5,250 | $723.10 | 13.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 20 | 20 | $2,000 | $380.42 | 19.0% |
About Dr. Robert Watson, M.D
Dr. Robert Watson, M.D is a Cardiovascular Disease healthcare provider based in Horsham, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952396376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Watson, M.D has received a total of $8,800 in payments from pharmaceutical and medical device companies, with $786.11 received in 2024. These payments were reported across 344 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($7,463).
As a Medicare-enrolled provider, Watson has provided services to 10,192 Medicare beneficiaries, totaling 15,790 services with total Medicare billing of $859,439. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Horsham, PA
- Active Since 09/12/2005
- Last Updated 12/04/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1952396376
Products in Payments
- CardioMEMS HF System (Device) $1,845
- ELIQUIS (Drug) $591.85
- ENTRESTO (Drug) $588.11
- HeartMate 3 Left Ventricular Dev (Device) $429.09
- Circulatory Support (Device) $395.71
- Impella (Device) $327.85
- XARELTO (Drug) $269.06
- LifeVest (Device) $201.52
- Corlanor (Drug) $184.33
- CAMZYOS (Drug) $161.43
- COREVALVE EVOLUT R (Device) $155.21
- VERQUVO (Drug) $147.86
- BRILINTA (Drug) $143.05
- VYNDAQEL (Drug) $136.82
- FARXIGA (Drug) $116.67
- Inpefa (Drug) $115.00
- JARDIANCE (Drug) $114.71
- Aquadex (Device) $113.15
- WATCHMAN Access System (Device) $111.38
- LEQVIO (Drug) $106.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Horsham
Dr. Bruce Klugherz, M.d, M.D
Cardiovascular Disease — Payments: $342,160
Cardiovascular Disease $342,160
Adam Cohen, Md, MD
Cardiovascular Disease — Payments: $273,704
Cardiovascular Disease $273,704
Dr. Aswin Mathew, M.d, M.D
Cardiovascular Disease — Payments: $20,163
Cardiovascular Disease $20,163
Asoka Balaratna, Md, MD
Cardiovascular Disease — Payments: $8,583
Cardiovascular Disease $8,583
Vamshi Mallavarapu, Md, MD
Cardiovascular Disease — Payments: $7,320
Cardiovascular Disease $7,320
Dr. Matthew Collins, D.o, D.O
Cardiovascular Disease — Payments: $6,615
Cardiovascular Disease $6,615